Martin Purpura;Ralf Jäger;Marvin Heuer;Scott Hagerman;Lorenzo De Ferra
发明人:
Lorenzo De Ferra,Marvin Heuer,Scott Hagerman,Martin Purpura,Ralf Jäger
申请号：
US13373649
公开号：
US20120141448A1
申请日:
2011.11.23
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
